MedTrace Logo

Extended Wear of a Steel and a Teflon Insulin Infusion Set

NCT03683368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-03-29

No results posted yet for this study

Summary

This is a cross-over study to evaluate if insulin infusion sets can be used up to 7 days.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

YpsoPump Orbit soft

Insulin infusion sets will be used for up to 7 days or until failure

DEVICE

YpsoPump Orbit micro

Insulin infusion sets will be used for up to 7 days or until failure

Sponsors & Collaborators

  • Ypsomed Diabetes Care AG

    lead INDUSTRY

Principal Investigators

  • Guido Freckmann, MD · Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

  • Andreas Buhr, Dr. · Ypsomed AG, Burgdorf, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03683368 on ClinicalTrials.gov